No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use*
-
Clinical Trials, Phase III as Topic
-
Hepatitis C / drug therapy*
-
Humans
-
Interferon alpha-2
-
Interferon-alpha* / therapeutic use*
-
Polyethylene Glycols*
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Recombinant Proteins
-
Research Design
Substances
-
Antiviral Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins
-
Polyethylene Glycols
-
peginterferon alfa-2b
-
peginterferon alfa-2a